Salivary microRNA in pancreatic cancer patients

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Humeau, Marine ^a,b,c   Vignolle Vidoni, Alix ^a,b,c   Sicard, Flavie ^a,b   Martins, Frédéric ^b,d   Bournet, Barbara ^a,b,c   Buscail, Louis ^a,b,c   Torrisani, Jérôme ^a,b   Cordelier, Pierre ^a,b  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU RANGUEIL   (France)

^d Université de Toulouse   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 21; MICRORNA 23A; MICRORNA 23B; MICRORNA 29C; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOSCOPY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC SCREENING; HUMAN; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PANCREAS CANCER; PILOT STUDY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; UPREGULATION; ADENOCARCINOMA; AGED; ANIMAL; DISEASE MODEL; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; SALIVA; TUMOR CELL LINE; VERY ELDERLY;

MUS;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, NUDE; MICRORNAS; MIDDLE AGED; PANCREATIC NEOPLASMS; SALIVA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84938558640     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130996     Document Type: Article

References (38)

1. Cancer Facts & Figures 2013 [Internet]. [cited 10 Feb 2014]. Available: http://www.cancer.org/ research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
2. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol Off J Am Soc Clin Oncol. 1997; 15: 2403-2413.
3. Pancreatic Cancer Action Network [Internet]. Available: http://www.pancan.org/
4. Humeau M, Torrisani J, Cordelier P. miRNA in clinical practice: Pancreatic cancer. Clin Biochem. 2013; doi: 10.1016/j.clinbiochem.2013.03.019
5. Xiao Y-F, Yong X, Fan Y-H, Lü M-H, Yang S-M, Hu C-J. microRNA detection in feces, sputum, pleural effusion and urine: novel tools for cancer screening (Review). Oncol Rep. 2013; 30: 535-544. doi: 10. 3892/or.2013.2525 PMID: 23754129
6. Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol. 2012; 41: 1897-1912. doi: 10.3892/ijo.2012.1647 PMID: 23026890
7. Cheng Y-SL, Rees T, Wright J. A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med. 2014; 3: 3. doi: 10.1186/2001-1326-3-3 PMID: 24564868
8. Yoshizawa JM, Wong DTW. Salivary microRNAs and oral cancer detection. Methods Mol Biol Clifton NJ. 2013; 936: 313-324. doi: 10.1007/978-1-62703-083-0-24
9. Matse JH, Yoshizawa J, Wang X, Elashoff D, Bolscher JGM, Veerman ECI, et al. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin Cancer Res Off J Am Assoc Cancer Res. 2013; 19: 3032-3038. doi: 10.1158/1078-0432.CCR-12-3505
10. Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C, et al. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PloS One. 2013; 8: e57502. doi: 10.1371/journal.pone.0057502 PMID: 23560033
11. Brinkmann O, Wong DTW. Salivary transcriptome biomarkers in oral squamous cell cancer detection. Adv Clin Chem. 2011; 55: 21-34. PMID: 22126022
12. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics Off J Metabolomic Soc. 2010; 6: 78-95. doi: 10.1007/s11306-009-0178-y
13. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park N-H, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010; 138: 949-957.e1-7. doi: 10.1053/j.gastro.2009.11.010 PMID: 19931263
14. Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012; 61: 582-588. doi: 10.1136/gutjnl-2011-300784 PMID: 21994333
15. Bournet B, Selves J, Grand D, Danjoux M, Hanoun N, Cordelier P, et al. Endoscopic Ultrasound-guided Fine-Needle Aspiration Biopsy Coupled With a KRAS Mutation Assay Using Allelic Discrimination Improves the Diagnosis of Pancreatic Cancer. J Clin Gastroenterol. 2014; doi: 10.1097/MCG.0000000000000053
16. Delpu Y, Lulka H, Sicard F, Saint-Laurent N, Lopez F, Hanoun N, et al. The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool. Schneider G, editor. PLoS ONE. 2013; 8: e55513. doi: 10.1371/journal.pone.0055513 PMID: 23383211
17. Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P. Targeting miR-21 for the Therapy of Pancreatic Cancer. Mol Ther. 2013; doi: 10.1038/mt.2013.35
18. Bournet B, Pointreau A, Souque A, Oumouhou N, Muscari F, Lepage B, et al. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Pancreatol Off J Int Assoc Pancreatol IAP Al. 2012; 12: 27-34. doi: 10.1016/j.pan.2011.12.003
19. Bournet B, Souque A, Senesse P, Assenat E, Barthet M, Lesavre N, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy. 2009; 41: 552-557. doi: 10.1055/s-0029-1214717 PMID: 19533561
20. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010; 56: 1733-1741. doi: 10.1373/clinchem.2010.147405 PMID: 20847327
21. Liu C-J, Lin S-C, Yang C-C, Cheng H-W, Chang K-W. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck. 2012; 34: 219-224. doi: 10.1002/hed.21713 PMID: 22083872
22. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, et al. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PloS One. 2013; 8: e66778. doi: 10.1371/journal.pone.0066778 PMID: 23825564
23. Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. J Dent Res. 2014; doi: 10.1177/0022034514531018
24. Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res Phila Pa. 2015; 8: 165-173. doi: 10.1158/1940-6207.CAPR-14-0192
25. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res Off J Am Assoc Cancer Res. 2012; 18: 4713-4724. doi: 10.1158/1078-0432.CCR-12-0035
26. Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011; 8: 706-713. doi: 10.4161/rna.8.5.16154 PMID: 21712654
27. Zhu W, Xu B. MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis. PloS One. 2014; 9: e103373. doi: 10.1371/journal.pone.0103373 PMID: 25098165
28. Du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, et al. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem. 2010; 56: 603-612. doi: 10. 1373/clinchem.2009.137364 PMID: 20093556
29. Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, et al. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis. Gene. 2014; 533: 389-397. doi: 10.1016/j.gene.2013.09.038 PMID: 24076132
30. Piepoli A, Tavano F, Copetti M, Mazza T, Palumbo O, Panza A, et al. Mirna expression profiles identify drivers in colorectal and pancreatic cancers. PloS One. 2012; 7: e33663. doi: 10.1371/journal.pone.0033663 PMID: 22479426
31. Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S, et al. c-MYC-regulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem. 2013; 288: 18121-18133. doi: 10.1074/jbc.M113.478560 PMID: 23649631
32. Sanchez-Martínez D, Krzywinska E, Rathore MG, Saumet A, Cornillon A, Lopez-Royuela N, et al. Alltrans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity. Int J Biochem Cell Biol. 2014; 49: 42-52. doi: 10.1016/j.biocel.2014.01.003 PMID: 24440757
33. Zheng H, Li W, Wang Y, Xie T, Cai Y, Wang Z, et al. miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer. Carcinogenesis. 2014; 35: 173-183. doi: 10.1093/carcin/bgt274 PMID: 23929433
34. Lian S, Shi R, Bai T, Liu Y, Miao W, Wang H, et al. Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by targeting apoptotic protease activating factor-1. Curr Pharm Des. 2013; 19: 6382-6389. PMID: 23865473
35. Liu X, Ru J, Zhang J, Zhu L, Liu M, Li X, et al. miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells. PloS One. 2013; 8: e64707. doi: 10.1371/journal.pone.0064707 PMID: 23785404
36. Shang J, Yang F, Wang Y, Wang Y, Xue G, Mei Q, et al. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells. J Cell Biochem. 2014; 115: 772-784. doi: 10.1002/jcb.24721 PMID: 24249161
37. Wang P, Zhang J, Zhang L, Zhu Z, Fan J, Chen L, et al. MicroRNA 23b Regulates Autophagy Associated With Radioresistance of Pancreatic Cancer Cells. Gastroenterology. 2013; 145: 1133-1143.e12. doi: 10.1053/j.gastro.2013.07.048 PMID: 23916944
38. Lau C, Kim Y, Chia D, Spielmann N, Eibl G, Elashoff D, et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem. 2013; 288: 26888-26897. doi: 10.1074/jbc. M113.452458 PMID: 23880764